thymoquinone has been researched along with Diabetes Mellitus, Type 2 in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 3 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmad, A; Ahmad, I; Ahmad, M; Ali, SM; Chaturvedi, A; Chavda, V; Chen, P; Desai, B; Khan, M; Paithankar, M; Panchal, DT; Patel, A; Patel, P; Patel, R; Saboo, BD; Shah, K; Sheikh, S | 1 |
| Abdel-Moneim, AH; Abdellatif, AAH; Al Rugaie, O; Alsharidah, AS; Alsharidah, M; Faisal Lutfi, M; Mobark, MA; Mohany, KM; Saleem, IY | 1 |
| Kapoor, VK; Malik, S; Negi, P; Singh, A | 1 |
| Dahiya, S; Dhingra, D; Dilbaghi, N; Kim, KH; Kumar, S; Rani, R | 1 |
| El-Mahmoudy, A; Matsuyama, H; Nikami, H; Shiina, T; Shimizu, Y; Takewaki, T | 1 |
1 review(s) available for thymoquinone and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Thymoquinone: A small molecule from nature with high therapeutic potential.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents; Antioxidants; Benzoquinones; Biological Availability; Breast Neoplasms; Carcinoma, Hepatocellular; Cardiomyopathies; Colonic Neoplasms; Diabetes Mellitus, Type 2; Humans; Liver Neoplasms; Nanoparticle Drug Delivery System; Neoplasms; Nervous System Diseases | 2021 |
1 trial(s) available for thymoquinone and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Thymoquinone with Metformin Decreases Fasting, Post Prandial Glucose, and HbA1c in Type 2 Diabetic Patients.
Topics: Administration, Oral; Adult; Animals; Benzoquinones; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Drug Evaluation, Preclinical; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Metformin; Mice; Middle Aged; Prospective Studies; Streptozocin | 2021 |
3 other study(ies) available for thymoquinone and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Thymoquinone Lowers Blood Glucose and Reduces Oxidative Stress in a Rat Model of Diabetes.
Topics: Animals; Antioxidants; Benzoquinones; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Models, Animal; Humans; Hypoglycemia; Kidney; Oxidative Stress; Rats | 2021 |
Improvement of antihyperglycemic activity of nano-thymoquinone in rat model of type-2 diabetes.
Topics: Administration, Oral; Animals; Benzoquinones; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Female; Hypoglycemic Agents; Nanoparticles; Particle Size; Rats; Rats, Wistar; Surface Properties | 2018 |
Macrophage-derived cytokine and nitric oxide profiles in type I and type II diabetes mellitus: effect of thymoquinone.
Topics: Animals; Benzoquinones; Blood Glucose; Cytokines; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Immunologic Factors; Interleukin-1; Macrophages, Peritoneal; Male; Nitric Oxide; Nitrites; Rats; Rats, Inbred OLETF; Tumor Necrosis Factor-alpha | 2005 |